BioXcel Therapeutics, Inc. (BTAIQ) Stock buybacks
BioXcel Therapeutics, Inc. (BTAIQ) annual stock buyback history — cash paid to repurchase common stock, per SEC filings.
$9.0MFY2021
| Fiscal year | Value | YoY |
|---|---|---|
| FY2021 | $9.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More BTAIQ financial trends
BTAIQ RevenueBTAIQ Net incomeBTAIQ Net marginBTAIQ Gross profitBTAIQ Gross marginBTAIQ Operating incomeBTAIQ Operating marginBTAIQ Operating cash flowBTAIQ Free cash flowBTAIQ Capital expendituresBTAIQ Return on equityBTAIQ Dividends paidBTAIQ Total assetsBTAIQ Total liabilitiesBTAIQ Shareholders’ equityBTAIQ overview →